Yilmaz, I. T. Et Al. 2023. Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse Model. ACTA PHYSIOLOGICA , 24.

Yilmaz, I. T., KORKMAZ, O. T., Kus, G., Kaya, E. M. O., MERAL EVİŞ, C. C., ESER, M., ... Ulupinar, E.(2023). Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse Model. ACTA PHYSIOLOGICA , 24.

Yilmaz, Isil Et Al. "Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse Model," ACTA PHYSIOLOGICA , 24, 2023

Yilmaz, Isil T. Et Al. "Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse Model." ACTA PHYSIOLOGICA , pp.24, 2023

Yilmaz, I. T. Et Al. (2023) . "Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse Model." ACTA PHYSIOLOGICA , p.24.

@article{article, author={Isil Tan Yilmaz Et Al. }, title={Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse Model}, journal={ACTA PHYSIOLOGICA}, year=2023, pages={24} }